tiprankstipranks
Trending News
More News >
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market

Senti Biosciences (SNTI) Financial Statements

Compare
224 Followers

Senti Biosciences Financial Overview

Senti Biosciences's market cap is currently $28.92M. The company's EPS TTM is $-0.69; its P/E ratio is -0.33; Senti Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 1.98M$ 3.29M$ 2.29M$ 394.00K
Gross Profit$ 0.00$ 1.98M$ 3.29M$ 2.29M$ 394.00K
Operating Income$ -61.04M$ -92.73M$ -62.08M$ -40.45M$ -24.69M
EBITDA$ -54.88M$ -61.34M$ -58.16M$ -37.44M$ -22.71M
Net Income$ -52.79M$ -71.06M$ -58.21M$ -55.32M$ -19.86M
Balance Sheet
Cash & Short-Term Investments$ 48.28M$ 35.93M$ 98.56M$ 56.03M$ 30.54M
Total Assets$ 97.84M$ 119.48M$ 180.79M$ 96.70M$ 48.34M
Total Debt$ 33.64M$ 37.67M$ 37.09M$ 22.73M$ 14.05M
Net Debt$ -14.64M$ 1.74M$ -20.53M$ -33.30M$ -16.49M
Total Liabilities$ 72.19M$ 52.57M$ 53.53M$ 36.33M$ 107.06M
Stockholders' Equity$ 25.65M$ 66.91M$ 127.26M$ 60.38M$ -58.71M
Cash Flow
Free Cash Flow$ -41.42M$ -64.43M$ -76.27M$ -40.18M$ -25.33M
Operating Cash Flow$ -41.40M$ -52.40M$ -34.90M$ -34.63M$ -24.17M
Investing Cash Flow$ 34.00K$ 30.08M$ -81.96M$ -5.54M$ 11.36M
Financing Cash Flow$ 53.73M$ 779.00K$ 118.55M$ 68.44M$ 38.05M
Currency in USD

Senti Biosciences Earnings and Revenue History

Senti Biosciences Debt to Assets

Senti Biosciences Cash Flow

Senti Biosciences Forecast EPS vs Actual EPS